NTHL1 and cancer: Impedance-based real-time cell analysis (RTCA) showed that the recorded cell index (CI), which correlated with the reported cell proliferation potential of the cancer cells, significantly decreased in the CP-FaP2 and CP-FaP3 treated PANC-1 cells (Fig. 9a).